BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10348272)

  • 21. Pharmacoeconomics of amifostine in ovarian cancer.
    Calhoun EA; Bennett CL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):102-7. PubMed ID: 10348268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials.
    Capizzi RL; Oster W
    Int J Hematol; 2000 Dec; 72(4):425-35. PubMed ID: 11197208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioprotectants: pharmacology and clinical applications of amifostine.
    Dorr RT
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):10-3. PubMed ID: 9794995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amifostine and radiation therapy: past, present, and future.
    Tannehill SP; Mehta MP
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection].
    Huang R; Yu H; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):708-11. PubMed ID: 12561384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of amifostine as a radioprotector.
    Wasserman TH; Brizel DM
    Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytoprotective effects of amifostine in the treatment of tumors].
    Burkon P; Petýrek P; Spurný V
    Vnitr Lek; 2003 Aug; 49(8):673-8. PubMed ID: 14518094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future directions in gynecologic cancer.
    Alberts DS
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):125-8. PubMed ID: 10348271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new administration schedule for amifostine as a radioprotector in cancer therapy.
    Wagner W; Radmard A; Schönekaes KG
    Anticancer Res; 1999; 19(3B):2281-3. PubMed ID: 10472344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):1-2. PubMed ID: 10348254
    [No Abstract]   [Full Text] [Related]  

  • 33. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
    Mehta V
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):42-6. PubMed ID: 15726522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapeutic studies with amifostine (Ethyol).
    Wasserman TH
    Semin Oncol; 1994 Oct; 21(5 Suppl 11):21-5. PubMed ID: 7973775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.
    Koukourakis MI
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):42-6. PubMed ID: 12577243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trials of amifostine and radiotherapy: effect on survival?
    Bourhis J; Thephamongkhol K; Pignon JP
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):62-6. PubMed ID: 15726526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-induced toxicities: the role of radioprotectants.
    Curran WJ
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
    Koukourakis MI; Yannakakis D
    Anticancer Res; 2001; 21(4B):2973-8. PubMed ID: 11712796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amifostine and hematologic effects.
    Sriswasdi C; Jootar S; Giles FJ
    J Med Assoc Thai; 2000 Apr; 83(4):374-82. PubMed ID: 10808697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.
    Bourhis J; Rosine D
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.